Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Anixa Biosciences Inc | form10k.htm |
| EX-32.1 - EXHIBIT 32.1 - Anixa Biosciences Inc | exhibit32_1.htm |
| EX-31.2 - EXHIBIT 31.2 - Anixa Biosciences Inc | exhibit31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - Anixa Biosciences Inc | exhibit31_1.htm |
| EX-23.1 - EXHIBIT 23.1 - Anixa Biosciences Inc | exhibit23_1.htm |
| EX-21 - EXHIBIT 21 - Anixa Biosciences Inc | exhibit21.htm |
| EX-3.8 - EXHIBIT 3.8 - Anixa Biosciences Inc | exhibit3_8.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 1350 of Title 18 of the United States Code, the undersigned, Michael J. Catelani, Chief Operating Officer and Chief Financial Officer of Anixa Biosciences, Inc. (the “Company”), hereby certifies that:
|
| 1. | The Company's Form 10-K Annual Report for the fiscal year ended October 31, 2019 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: January 9, 2020 |
| /s/ Michael J. Catelani |
|
|
|
| Michael J. Catelani |
|
|
|
| Chief Operating Officer and Chief Financial Officer |
|